The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Monday 22 December 2014
The National Institute for Health and Care Excellence (NICE) have today published the draft guidance on their recent Multiple Technology Appraisal of certain ovarian cancer drugs. The NICE committee has been consulting on a review of the use of topotecan (Hycamtin), pegylated liposomal doxorubicin...
Wednesday 10 December 2014
The 16th annual Britain Against Cancer conference took place yesterday. Target Ovarian Cancer staff members and advocates attended the conference, and also had an exhibition stand to raise awareness of our work with delegates. The stand was very well received with a steady flow of delegates...
Tuesday 28 October 2014
In today’s news, you may have read about a research study which has looked to see if tea, citrus fruits, some vegetables and juices affect your risk of ovarian cancer. The study found that consuming more than one cup of black tea every day may reduce your life time risk of developing ovarian cancer...
Friday 24 October 2014
In today’s news, you may have read or heard about the drug olaparib receiving a recommendation from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use. Olaparib is one of several PARP inhibitor drugs that are currently being trialled, which reduce the ability of...